InsidersTradesSigma
Follow the PRO MEDICUS LIMITED stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are listed on AU AU, under the oversight of ASX. Market capitalisation: €21.9bn. The latest transaction was filed on 29 May 2026 (Initial Substantial Holding). Among the most active insiders: AustralianSuper Pty Ltd. All data is openly available.
Analysts rate PRO MEDICUS LIMITED Buy (bullish), based on 15 analysts. Average price target: A$180.44.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
PRO MEDICUS LIMITED is an Australian company specializing in software solutions for medical imaging. It provides tools to enhance the efficiency and quality of healthcare services.